IF WE use deep learning on neuro-imaging, can we detect earlier and optimize diagnostic time and quality?
Neuro-psychiatric disorders are the third leading cause of global burden of disease, with an estimated impact of 16.3 Trillion USD. Despite the huge impact they have, and the increasing international focus on them due to the pandemic, the world has not seen revolutionary treatments in this space.
This is because clinicians lack tools that can't help in early screening, differential diagnosis and individualized modeling. If they had these tools, they could recruit patients for clinical trials for revolutionary new treatments and therapies, as well as personalize treatment for an individual.
BrainSightAI are here to change that.
AI reduces diagnostic complexity and aid psychiatrists to scale their diagnostics.
BrainSightAI founded by Laina Emmanuel and Rimjhim Agrawal creates AI-based diagnostic tools that can help in functional investigation of the brain. These tools can aid psychiatrists and neurologists in diagnosing mental disorders using MRI scans, and neurosurgeons in pre-surgical planning, especially for comatose and cognitively challenged patients. The AI-powered software empowers doctors with functional reports in a matter of hours.
The tool uses AI-based imaging markers to identify and classify disorders, such as schizophrenia, bipolar disorder and early forms of dementia, and to simulate effects of surgery on brain functionality. BrainSightAI is pilot testing their prototype with two hospital chains, including the largest private hospital chain in India.
GOAL 3: GOOD HEALTH AND WELL-BEING
3DEXPERIENCE Lab open innovation laboratory and accelerator program is helping BrainSightAI, an Indian startup in neuroscience, in its efforts to revolutionize the diagnosis and prognosis of neuro-psychiatric disorders using artificial intelligence. The BrainSightAI MRI solutions for functional and structural investigation give an unprecedented view into the patient, enabling early screening, diagnosis and modeling. It combines AI and neuroscience to enable greater precision in neurological and psychiatric investigation for accelerated patient outcomes.
BrainSightAI is an AI enabled application suite developed by a diverse and expert team of scientists, researchers and designers. It provides evidence-based treatment hooks for psychiatrists and neurologists; and a private and empathetic digital aid for patients.
IF WE give robotic companions to children, can we spark interaction & motivation to learn, play & progress?
Although 75 percent of blindness is avoidable, At least 1 billion people have a visual impairment that could have been prevented or treated. There are 2 principal reasons to this problem: There are not enough medical specialists and hardware is expensive, difficult to setup and non-portable.
Do you think your project is the next big thing?
Join the team !